# Sumitomo Pharma Co., Ltd. (DNPUF)

> 医疗保健 · JP · 以 JPY 报告

Sponda 的基本面指标，已按通胀调整。

[HTML 版本](https://sponda.capital/zh/DNPUF/fundamentals)

## 年度数据

| 年份 | 营业收入 (M) | 净利润 (M) | FCF (M) | 债务 (M) | 股东权益 (M) |
| --- | --- | --- | --- | --- | --- |
| 2027 | ¥ 128.56B | ¥ 16.87B | ¥ -8.05B | ¥ 159.50B | ¥ 405.60B |
| 2026 | ¥ 455.77B | ¥ 108.12B | ¥ 69.21B | ¥ 218.55B | ¥ 294.31B |
| 2025 | ¥ 398.83B | ¥ 23.63B | ¥ 8.00B | ¥ 305.42B | ¥ 169.48B |
| 2024 | ¥ 314.56B | ¥ -314.96B | ¥ -257.62B | ¥ 427.86B | ¥ 156.06B |
| 2023 | ¥ 555.54B | ¥ -74.51B | ¥ -805.00M | ¥ 334.72B | ¥ 406.75B |
| 2022 | ¥ 560.04B | ¥ 56.41B | ¥ 17.75B | ¥ 269.05B | ¥ 607.89B |
| 2021 | ¥ 515.95B | ¥ 56.22B | ¥ 124.80B | ¥ 273.82B | ¥ 580.57B |
| 2020 | ¥ 479.37B | ¥ 40.47B | ¥ 32.55B | ¥ 297.98B | ¥ 529.49B |
| 2019 | ¥ 450.62B | ¥ 47.71B | ¥ 35.12B | ¥ 30.94B | ¥ 498.14B |
| 2018 | ¥ 452.99B | ¥ 36.14B | ¥ 80.18B | ¥ 47.40B | ¥ 452.72B |
| 2017 | ¥ 408.37B | ¥ 28.76B | ¥ 0 | ¥ 68.00B | ¥ 460.66B |
| 2016 | ¥ 404.06B | ¥ 24.75B | ¥ 0 | ¥ 51.01B | ¥ 446.47B |
| 2015 | ¥ 373.29B | ¥ 15.53B | ¥ 0 | ¥ 86.52B | ¥ 451.02B |
| 2014 | ¥ 390.51B | ¥ 20.21B | ¥ 0 | ¥ 95.00B | ¥ 398.54B |
| 2013 | ¥ 358.67B | ¥ 10.36B | ¥ 0 | ¥ 115.00B | ¥ 349.25B |
| 2012 | ¥ 367.17B | ¥ 9.04B | N/A | ¥ 128.00B | ¥ 319.23B |
| 2011 | ¥ 396.87B | ¥ 17.56B | ¥ 47.99B | ¥ 153.60B | ¥ 323.98B |
| 2010 | ¥ 309.17B | ¥ 21.87B | ¥ 21.45B | ¥ 165.80B | ¥ 343.48B |
| 2009 | ¥ 201.69B | ¥ 14.08B | ¥ 11.78B | ¥ 0 | ¥ 324.41B |

此视图中不可用的列：annualPriceMultiples, dividends。它们需要实时市场数据，仅在 HTML 页面上显示。

## 杠杆与流动性

| 指标 | 数值 |
| --- | --- |
| 总债务 / 股东权益 | 0.39 |
| 总负债 / 股东权益 | 1.07 |
| 流动比率 | 1.21 |

## 债务覆盖

| 指标 | 数值 |
| --- | --- |
| 总债务 / 盈利 | 97.32 |
| 总债务 / 自由现金流 | 15.89 |

## 其他视图

- [指标](https://sponda.capital/zh/DNPUF.md)
- [图表](https://sponda.capital/zh/DNPUF/charts.md)
- [对比](https://sponda.capital/zh/DNPUF/compare.md)
- [指标定义](https://sponda.capital/zh/screener.md)

数据截至 2026-08-29。